158 related articles for article (PubMed ID: 26555615)
1. Nanoparticulate fingolimod delivery system based on biodegradable poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV): design, optimization, characterization and in-vitro evaluation.
Rezaie Shirmard L; Bahari Javan N; Khoshayand MR; Kebriaee-Zadeh A; Dinarvand R; Dorkoosh FA
Pharm Dev Technol; 2017 Nov; 22(7):860-870. PubMed ID: 26555615
[TBL] [Abstract][Full Text] [Related]
2. Fabrication of long-acting insulin formulation based on poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) nanoparticles: preparation, optimization, characterization, and in vitro evaluation.
Bayrami S; Esmaili Z; SeyedAlinaghi S; Jamali Moghadam SR; Bayrami S; Akbari Javar H; Rafiee Tehrani M; Dorkoosh FA
Pharm Dev Technol; 2019 Feb; 24(2):176-188. PubMed ID: 29557733
[TBL] [Abstract][Full Text] [Related]
3. Application of Artificial Neural Networks in the Design and Optimization of a Nanoparticulate Fingolimod Delivery System Based on Biodegradable Poly(3-Hydroxybutyrate-Co-3-Hydroxyvalerate).
Shahsavari S; Rezaie Shirmard L; Amini M; Abedin Dokoosh F
J Pharm Sci; 2017 Jan; 106(1):176-182. PubMed ID: 27666377
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic release from biodegradable PHBV microparticles.
Sendil D; Gürsel I; Wise DL; Hasirci V
J Control Release; 1999 May; 59(2):207-17. PubMed ID: 10332055
[TBL] [Abstract][Full Text] [Related]
5. Encapsulation of Ellipticine in poly-(3-hydroxybutyrate-co-3-hydroxyvalerate) based nanoparticles and its in vitro application.
Masood F; Chen P; Yasin T; Fatima N; Hasan F; Hameed A
Mater Sci Eng C Mater Biol Appl; 2013 Apr; 33(3):1054-60. PubMed ID: 23827542
[TBL] [Abstract][Full Text] [Related]
6. Prolonged injectable formulation of Nafarelin using in situ gel combination delivery system.
Alizadeh B; Bahari Javan N; Akbari Javar H; Khoshayand MR; Dorkoosh F
Pharm Dev Technol; 2018 Feb; 23(2):132-144. PubMed ID: 28430010
[TBL] [Abstract][Full Text] [Related]
7. Microencapsulation of antibiotic rifampicin in poly(3-hydroxybutyrate-co-3-hydroxyvalerate).
Durán N; Alvarenga MA; Da Silva EC; Melo PS; Marcato PD
Arch Pharm Res; 2008 Nov; 31(11):1509-16. PubMed ID: 19023549
[TBL] [Abstract][Full Text] [Related]
8. Improving the
Rezaie Shirmard L; Ghofrani M; Bahari Javan N; Bayrami S; Tavassoli A; Rezaie A; Amini M; Kebriaee-Zadeh A; Rouini MR; Dinarvand R; Rafiee-Tehrani M; Dorkoosh FA
Drug Dev Ind Pharm; 2020 Feb; 46(2):318-328. PubMed ID: 31976771
[TBL] [Abstract][Full Text] [Related]
9. Preparation, characterization and evaluation of antibacterial properties of epirubicin loaded PHB and PHBV nanoparticles.
Perveen K; Masood F; Hameed A
Int J Biol Macromol; 2020 Feb; 144():259-266. PubMed ID: 31821825
[TBL] [Abstract][Full Text] [Related]
10. Preparation, statistical optimisation and in vitro characterisation of poly (3-hydroxybutyrate-co-3-hydroxyvalerate)/poly (lactic-co-glycolic acid) blend nanoparticles for prolonged delivery of teriparatide.
Bahari Javan N; Rezaie Shirmard L; Jafary Omid N; Akbari Javar H; Rafiee Tehrani M; Abedin Dorkoosh F
J Microencapsul; 2016 Aug; 33(5):460-474. PubMed ID: 27424890
[TBL] [Abstract][Full Text] [Related]
11. [Preparation and characterization of prednisolone-poly (hydroxybutyrate-co-hydroxyvalerate) nanoparticles].
Chen JH; Shagufta M; Davis SS
Yao Xue Xue Bao; 2002 Jun; 37(6):473-6. PubMed ID: 12579810
[TBL] [Abstract][Full Text] [Related]
12. Long-circulating polyhydroxybutyrate-co-hydroxyvalerate nanoparticles for tumor targeted docetaxel delivery: Formulation, optimization and in vitro characterization.
Vardhan H; Mittal P; Adena SK; Mishra B
Eur J Pharm Sci; 2017 Mar; 99():85-94. PubMed ID: 28002762
[TBL] [Abstract][Full Text] [Related]
13. Effect of emulsification-diffusion parameters on the formation of poly (3-hydroxybutyrate-co-3-hydroxyvalerate) particles.
Göz E; Karakeçili A
Artif Cells Nanomed Biotechnol; 2016; 44(1):226-34. PubMed ID: 25058033
[TBL] [Abstract][Full Text] [Related]
14. Biomedical Applications of the Biopolymer Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV): Drug Encapsulation and Scaffold Fabrication.
Rodríguez-Cendal AI; Gómez-Seoane I; de Toro-Santos FJ; Fuentes-Boquete IM; Señarís-Rodríguez J; Díaz-Prado SM
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511432
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of flurbiprofen-loaded poly(3-hydroxybutyrate-co-3-hydroxyvalerate) microspheres.
Coimbra PA; De Sousa HC; Gil MH
J Microencapsul; 2008 May; 25(3):170-8. PubMed ID: 18382923
[TBL] [Abstract][Full Text] [Related]
16. Poly(3-hydroxybutyrate-co-epsilon-caprolactone) copolymers and poly(3-hydroxybutyrate-co-3-hydroxyvalerate-co-epsilon-caprolactone) terpolymers as novel materials for colloidal drug delivery systems.
Pignatello R; Musumeci T; Impallomeni G; Carnemolla GM; Puglisi G; Ballistreri A
Eur J Pharm Sci; 2009 Jun; 37(3-4):451-62. PubMed ID: 19504659
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) microspheres for the sustained release of 5-fluorouracil.
Khang G; Kim SW; Cho JC; Rhee JM; Yoon SC; Lee HB
Biomed Mater Eng; 2001; 11(2):89-103. PubMed ID: 11352116
[TBL] [Abstract][Full Text] [Related]
18. Preparation, Optimization and Physicochemical Characterization of Aripiprazole Loaded Nano-porous in situ Forming Implant.
Hedayati A; Yazdi SG; Dehghankelishadi P; Javan NB; Akbari H; Dorkoosh FA
Pharm Nanotechnol; 2017; 5(2):138-147. PubMed ID: 28530539
[TBL] [Abstract][Full Text] [Related]
19. The release of diazepam from poly(hydroxybutyrate-hydroxyvalerate) microspheres.
Chen J; Davis SS
J Microencapsul; 2002; 19(2):191-201. PubMed ID: 11837974
[TBL] [Abstract][Full Text] [Related]
20. Hydrocortisone loaded poly-(3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles for topical ophthalmic administration: Preparation, characterization and evaluation of ophthalmic toxicity.
Álvarez-Álvarez L; Barral L; Bouza R; Farrag Y; Otero-Espinar F; Feijóo-Bandín S; Lago F
Int J Pharm; 2019 Sep; 568():118519. PubMed ID: 31310791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
